SAVIENT PHARMACEUTICALS INC — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$18.0M

Net Income/Loss (FY2012)

-$118.3M

Total Assets (FY2012)

$119.2M

Total Equity (FY2012)

-$138.3M

Cash Flows from Operating Activities (FY2012)

-$114.7M

Source: SAVIENT PHARMACEUTICALS INC 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.